Fate Therapeutics Inc (NASDAQ:FATE)’s traded shares stood at 1.03 million during the last session, with the company’s beta value hitting 1.98.The FATE share’s 52-week high
In the last trading session, 2.28 million Fate Therapeutics Inc (NASDAQ:FATE) shares changed hands as the company’s beta touched 2.00. With the company’s per share
In last trading session, Fate Therapeutics Inc (NASDAQ:FATE) saw 3.8 million shares changing hands with its beta currently measuring 2.02. Company’s recent per share price
In recent trading session, Fate Therapeutics Inc (NASDAQ:FATE) saw 1.16 million shares changing hands at last check today with its beta currently measuring 2.02. Company’s
Fate Therapeutics Inc (NASDAQ:FATE) has a beta value of 1.95 and has seen 4.67 million shares traded in the last trading session. The company, currently
Fate Therapeutics Inc (NASDAQ:FATE) has a beta value of 1.95 and has seen 2.68 million shares traded in the last trading session. The company, currently
During the last session, Fate Therapeutics Inc (NASDAQ:FATE)’s traded shares were 5.63 million, with the beta value of the company hitting 1.93. At the end
During the last session, Fate Therapeutics Inc (NASDAQ:FATE)’s traded shares were 2.85 million, with the beta value of the company hitting 1.94. At the end
In today’s recent session, 0.85 million shares of the Fate Therapeutics Inc (NASDAQ:FATE) have been traded, and its beta is 1.93. Most recently the company’s
Fate Therapeutics Inc (NASDAQ:FATE)’s traded shares stood at 2.47 million during the last session, with the company’s beta value hitting 1.93. At the close of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
